TNON (Tenon Medical) FCF Margin %: -218.71% (As of Mar. 2026)


TNON Tenon Medical Inc TNON
38 GF Score
Price $0.29
GF Value $0.35
Valuation Modestly Undervalued
! 7 Warning Signs
View Full Analysis

What is Tenon Medical FCF Margin %?

Tenon Medical TNON -10.39% 38 FCF Margin % is -218.71% as of Mar. 2026. GuruFocus rates TNON with a GF Score™ of 38/100 and a GF Value™ of $0.35 (Modestly Undervalued). The stock has 7 warning signs investors should review. Among 818 Medical Devices & Instruments companies, Tenon Medical ranks worse than 89.24% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Tenon Medical's Free Cash Flow for the three months ended in Mar. 2026 was $-3.02 Mil. Tenon Medical's Revenue for the three months ended in Mar. 2026 was $1.38 Mil. Therefore, Tenon Medical's FCF Margin % for the quarter that ended in Mar. 2026 was -218.71%.

As of today, Tenon Medical's current FCF Yield % is -331.80%.

The historical rank and industry rank for Tenon Medical's FCF Margin % or its related term are showing as below:

TNON' s FCF Margin % Range Over the Past 10 Years
Min: -2746.25   Med: -403.99   Max: -245.33
Current: -245.33


During the past 6 years, the highest FCF Margin % of Tenon Medical was -245.33%. The lowest was -2746.25%. And the median was -403.99%.

TNON's FCF Margin % is ranked worse than
89.24% of 818 companies
in the Medical Devices & Instruments industry
Industry Median: -0.375 vs TNON: -245.33


Tenon Medical FCF Margin % Related Terms


Tenon Medical FCF Margin % Historical Data

* Premium members only.

The historical data trend for Tenon Medical's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tenon Medical FCF Margin % Chart

Tenon Medical Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
FCF Margin %
Get a 7-Day Free Trial -2,746.25 -1,862.81 -428.42 -307.11 -279.36

Tenon Medical Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -342.01 -392.55 -326.00 -150.17 -218.71

TNON vs XAIR, VVOS, BMRA: FCF Margin % Comparison

For the Medical Devices subindustry, Tenon Medical's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tenon Medical FCF Margin % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Tenon Medical's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Tenon Medical's FCF Margin % falls into.


TNON
38GF Score
Tenon Medical Inc TNON
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Tenon Medical FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Tenon Medical's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-11.018/3.944
=-279.36 %

Tenon Medical's FCF Margin for the quarter that ended in Mar. 2026 is calculated as

FCF Margin=Free Cash Flow (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-3.016/1.379
=-218.71 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of -218.71% mean?
Tenon Medical (TNON) has a FCF Margin % of -218.71% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Tenon Medical and its competitors. According to the industry distribution chart, Tenon Medical ranks #730 out of 818 companies in the Medical Devices & Instruments industry, placing it in the top 89.2%.
Is Tenon Medical's FCF Margin % too high?
Tenon Medical's current FCF Margin % is -218.71%. Based on the distribution chart, Tenon Medical ranks #730 out of 818 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Tenon Medical has a GF Score™ of 38/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Tenon Medical's FCF Margin % compare to XAIR and VVOS?
According to the Medical Devices & Instruments industry distribution chart, Tenon Medical ranks #730 out of 818 companies for FCF Margin %. This places Tenon Medical in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Devices & Instruments company?
A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Tenon Medical and its competitors. Tenon Medical's current FCF Margin % is -218.71%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tenon Medical stock overvalued right now?
Based on GuruFocus' analysis, Tenon Medical (TNON) is currently considered Modestly Undervalued. The stock's GF Value™ is $0.35, compared to a current price of $0.29 — trading 18% below its estimated fair value. The current FCF Margin % is -218.71%. Tenon Medical's overall GF Score™ is 38/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Tenon Medical (TNON), the current FCF Margin % is -218.71% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Tenon Medical (TNON) Overvalued in 2026?

Based on GuruFocus' analysis, Tenon Medical stock appears to be undervalued. The current stock price of $0.29 is trading 18% below its estimated GF Value™ of $0.35. GuruFocus considers Tenon Medical to be Modestly Undervalued.

Key valuation signals for TNON:

  • FCF Margin %: -218.71%
  • GF Value™: $0.35 vs. price of $0.29 (18% below fair value)
  • GF Score™: 38/100 with 7 warning signs

No single metric tells the full story. See the TNON stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Tenon Medical Business Description

Address 104 Cooper Court, Los Gatos, CA, USA, 95032
Tenon Medical Inc is a medical device company that has minimally invasive approach to the sacroiliac joint (the SI Joint) using a single, robust, titanium implant for the treatment of the common types of SI Joint disorders that cause lower back pain. The Company is focused on three commercial opportunities; Primary SI Joint procedures, Revision procedures of failed SI Joint implants, and SI Joint fusion adjunct to a spine fusion construct. The company derives the majority of its revenue from sales of The Catamaran System to a limited number of clinicians.
38GF Score

Get the complete analysis for TNON

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.29
Price
$0.35
GF Value